(Q33625004)

English

Hepcidin-25 is a marker of the response rather than resistance to exogenous erythropoietin in chronic kidney disease/chronic heart failure patients

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Hepcidin-25 is a marker of the response rather than resistance to exogenous erythropoietin in chronic kidney disease/chronic heart failure patients (English)

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

0 references

1 reference

based on heuristic

inferred from title

chronic heart failure

1 reference

based on heuristic

inferred from title

Dorine W Swinkels

6

object named as

Dorine W Swinkels

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Coby Laarakkers

5

object named as

Coby Laarakkers

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

author name string

Karien van der Putten

1

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Kim E Jie

2

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Daan van den Broek

3

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Rob J Kraaijenhagen

4

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Branko Braam

7

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Carlo A Gaillard

8

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

publication date

3 July 2010

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

European Journal of Heart Failure

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

12

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

9

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

943-950

1 reference

Europe PubMed Central

PubMed publication ID

28 July 2017

Mechanisms of Disease: erythropoietin resistance in patients with both heart and kidney failure

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ099

21 January 2018

Epoetin requirements predict mortality in hemodialysis patients

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ099

21 January 2018

Secondary analysis of the CHOIR trial epoetin-alpha dose and achieved hemoglobin outcomes

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ099

21 January 2018

IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ099

21 January 2018

Hepcidin inhibits in vitro erythroid colony formation at reduced erythropoietin concentrations

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ099

21 January 2018

Detection of serum hepcidin in renal failure and inflammation by using ProteinChip System

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ099

21 January 2018

Hepcidin--a potential novel biomarker for iron status in chronic kidney disease

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ099

21 January 2018

Chronic heart failure leads to an expanded plasma volume and pseudoanaemia, but does not lead to a reduction in the body's red cell volume.

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ099

21 January 2018

Hepcidin: from discovery to differential diagnosis

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ099

21 January 2018

Erythropoietin mediates hepcidin expression in hepatocytes through EPOR signaling and regulation of C/EBPalpha

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ099

21 January 2018

Plasma hepcidin levels are elevated but responsive to erythropoietin therapy in renal disease

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ099

21 January 2018

Advances in quantitative hepcidin measurements by time-of-flight mass spectrometry

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ099

21 January 2018

Cardiorenal syndrome

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ099

21 January 2018

ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ099

21 January 2018

ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Update the [...]

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ099

21 January 2018

How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ099

21 January 2018

(Pre)analytical imprecision, between-subject variability, and daily variations in serum and urine hepcidin: implications for clinical studies.

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ099

21 January 2018

Association of prohepcidin and hepcidin-25 with erythropoietin response and ferritin in hemodialysis patients

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ099

21 January 2018

Predictors of the response to treatment in anemic hemodialysis patients with high serum ferritin and low transferrin saturation

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ099

21 January 2018

Ferric carboxymaltose in patients with heart failure and iron deficiency

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ099

21 January 2018

Identification of TWSG1 as a second novel erythroid regulator of hepcidin expression in murine and human cells

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ099

21 January 2018

Erythropoietin in cancer-related anemia

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ099

21 January 2018

Immunoassay for human serum hepcidin

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ099

21 January 2018

High levels of GDF15 in thalassemia suppress expression of the iron regulatory protein hepcidin

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ099

21 January 2018

Associations between Changes in Hemoglobin and Administered Erythropoiesis-Stimulating Agent and Survival in Hemodialysis Patients

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ099

21 January 2018

Identifiers

10.1093/EURJHF/HFQ099

1 reference

https://api.fatcat.wiki/v0/release/asri3tcmwrgc3apnx4blmubufy

30 July 2022

based on heuristic

mapped directly with Wikidata item

release_asri3tcmwrgc3apnx4blmubufy

1 reference

https://api.fatcat.wiki/v0/release/asri3tcmwrgc3apnx4blmubufy

30 July 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

https://api.fatcat.wiki/v0/release/asri3tcmwrgc3apnx4blmubufy

30 July 2022

based on heuristic

mapped directly with Wikidata item

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33625004&oldid=2067361236"